Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001170918-07-000191

Options or other derivatives

  • Chief Marketing Officer sold 53,538.86 shares
  • Chief Marketing Officer acquired 11,250,000 shares (grant or award)
  • Chief Marketing Officer disposed of 174,328,512 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
WALKER SCOTT Chief Marketing Officer 2007-03-08 Other disposition · Options (Right to Buy) −174,328,512 0 D
WALKER SCOTT Chief Marketing Officer 2007-03-08 Grant or award · Options (Right to Buy) +11,250,000 11,250,000 D
WALKER SCOTT Chief Marketing Officer 2007-03-08 Sale · Series C Convertible Preferred Stock −53,538.86 108,039.14 D
Loading xslF345X02/sam07-073_ex.xml…